Electrocardiographic and echocardiographic characteristics of patients with hypertrophic obstructive cardiomyopathy at one year after left ventricular outflow tract dredging

doi:10.16138/j.1673-6087.2025.02.09

Abstract

Abstract:

Objective To investigate the changes and characteristics of electrocardiogram and echocardiography in patients with hypertrophic obstructive cardiomyopathy at 1 year after left ventricular outflow tract dredging.Methods To investigate patients diagnosed with hypertrophic obstructive cardiomyopathy who underwent left ventricular outflow tract dredging surgery in Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from January 1 to December 31 in 2018. A total of 38 cases were enrolled, the clinical features, electrocardiogram and echocardiography data before, 1 year after surgery were collected for comparative analysis and summarizations.Results There were significant statistical differences in the proportion of left ventricular hypertrophy (LVH) and complete left bundle branch block (CLBBB) on electrocardiogram (52.6% vs 12.9%, P<0.01) and (2.6% vs 58.1%, P<0.01), respectively. Echocardiography showed a significant reduction in left ventricular ejection fraction (LVEF) (68.50%±4.11% vs 63.87%±4.00%, P<0.01). In post-surgery patients with CLBBB (67.46%±2.96% vs 64.83%±4.20%, P=0.082), there was a significant reduction in LVEF (69.39%±5.29% vs 63.40%±4.15%, P<0.01), while there was no statistical difference in patients without CLBBB.Conclusions Left ventricular outflow tract dredging surgery could effectively reduce the proportion of LVH in patients with hypertrophic obstructive cardiomyopathy and alleviate outflow tract obstruction. However, patients who developed CLBBB after surgery showed a tendency of reduced LVEF.

Key words: Hypertrophic obstructive cardiomyopathy, Left ventricular outflow tract dredging, Electrocardiogram, Left ventricular hypertrophy, Complete left bundle branch block, Left ventricular ejection fraction

CLC Number:

R541

WANG Hongzhen, LIU Xia. Electrocardiographic and echocardiographic characteristics of patients with hypertrophic obstructive cardiomyopathy at one year after left ventricular outflow tract dredging[J]. Journal of Internal Medicine Concepts & Practice, 2025, 20(02): 152-156.

Figures/Tables 7

Table 1

Figure 1

Figure 2

Figure 3

Table 2

Table 3

Table 4

References 10

[1]	Canepa M, Olivotto I. Evolving epidemiology of hypertrophic cardiomyopathy: shifting the focus from instant to lifetime risk awareness[J]. Circ Heart Fail, 2022, 15(9):e00987.
[2]	李杰, 翁凡, 陈楠, 等. 改良Morrow术治疗肥厚型梗阻性心肌病: 318例的单中心回顾性研究[J/OL]. 中国胸心血管外科临床杂志, 2024. http://kns.cnki.net/kcms/detail/51.1492.r.20240415.1649.004.html.
[3]	Rastegar H, Boll G, Rowin EJ, et al. Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience[J]. Ann Cardiothorac Surg, 2017, 6(4): 353-363.
[4]	Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2014, 35(39):2733-2779. doi: 10.1093/eurheartj/ehu284 pmid: 25173338
[5]	Bacharova L, Ugander M. Left ventricular hypertrophy: the relationship between the electrocardiogram and cardiovascular magnetic resonance imaging[J]. Ann Noninvasive Electrocardiol, 2014, 19(6): 524-533.
[6]	陈新. 黄宛临床心电图学[M]. 6 版. 北京: 人民卫生出版社, 2009: 420-430.
[7]	Sasson Z, Prieur T, Skrobik Y, et al. Aortic regurgitation: a common complication after surgery for hypertrophic obstructive cardiomyopathy[J]. J Am Coll Cardiol, 1989, 13(1): 63-67. pmid: 2909583
[8]	Iacovoni A, Spirito P, Simon C, et al. A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy[J]. Eur Heart J, 2012, 33(16):2080-2087. doi: 10.1093/eurheartj/ehs064 pmid: 22522842
[9]	Dearani JA, Ommen SR, Gersh BJ, et al. Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience[J]. Nat Clin Pract Cardiovasc Med, 2007, 4(9): 503-512. doi: 10.1038/ncpcardio0965 pmid: 17712363
[10]	李晓艺, 吴宏祥, 王若冰, 等. 改良Morrow术治疗儿童肥厚型梗阻性心肌病远期疗效的单中心回顾性研究[J]. 中国胸心血管外科临床杂志, 2024, 31(7): 985-990.

Related Articles 10

[1]	BALASUBRAMANIAN S^1*, NARUKA Mahaveer Singh², TEWARI Gaurav³. Electrocardiogram Signal Denoising Using Optimized Adaptive Hybrid Filter with Empirical Wavelet Transform [J]. J Shanghai Jiaotong Univ Sci, 2025, 30(1): 66-80.
[2]	LU Wei, LI Xuting, YU Weibin, XIA Yimeng, FAN Qiuwei. Continuous cardiac index in patients related with left ventricular ejection fraction in preanesthesia assessment for gastroenteroscopy [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 152-156.
[3]	. [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(06): 349-354.
[4]	. [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(03): 161-166.
[5]	. [J]. Journal of Diagnostics Concepts & Practice, 2014, 13(06): 593-596.
[6]	. [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(01): 28-31.
[7]	. [J]. Journal of Diagnostics Concepts & Practice, 2010, 9(04): 331-334.
[8]	. [J]. Journal of Diagnostics Concepts & Practice, 2008, 7(04): 387-389.
[9]	. [J]. Journal of Diagnostics Concepts & Practice, 2008, 7(04): 390-393.
[10]	. [J]. Journal of Diagnostics Concepts & Practice, 2007, 6(02): 119-122.

项目	术前	术后1年随访	t	P
心室率（次/min）	64.97±15.62	73.87±11.77	2.517	0.014
PR间期（ms）	157.33±23.31	167.61±25.50	1.723	0.090
QRS间期（ms）	99.22±12.01	138.97±23.23	8.588	0.000
QT间期（ms）	407.58±34.60	415.74±37.82	0.922	0.302
QTc间期（ms）	425.39±33.48	455.16±31.86	3.711	0.000
V5 R波振幅（mV）	2.42±1.14	1.27±0.81	-4.707	0.000
V1 S波振幅（mV）	1.99±0.76	2.45±0.82	2.377	0.020

项目	术前	术后1年随访	t	P
AO（mm）	32.84±3.02	32.93±3.38	0.117	0.907
LAD（mm）	45.87±5.08	42.07±4.79	-2.611	0.037
LVEDd（mm）	45.87±5.08	47.53±4.42	1.42	0.160
LVESd（mm）	28.21±3.53	30.40±4.05	2.379	0.020
IVSd（mm）	18.37±3.66	11.70±2.67	-8.37	0.000
LVPWT(mm)	11.10±1.54	9.90±1.12	-3.596	0.001
LVEDV（mL）	96.92±31.27	107.43±23.76	1.525	0.132
LVESV（mL）	31.47±9.90	38.73±10.60	2.911	0.005
LVEF（%）	68.50±4.11	63.87±4.00	-4.666	0.000
LVFS（%）	37.95±4.23	34.67±3.05	-3.547	0.001
SV（mL）	68.08±18.25	68.47±15.38	0.093	0.926

项目	术前	术后1年随访	t	P
AO（mm）	32.83±3.36	32.80±3.32	0.029	0.977
LAD(mm)	43.89±4.08	42.47±4.67	0.933	0.358
LVEDd(mm)	44.83±5.60	49.20±4.84	-2.37	0.024
LVESd(mm)	27.39±3.68	32.13±3.64	-3.705	0.001
IVSd(mm)	18.44±3.29	11.33±2.22	7.109	0.000
LVPWT(mm)	10.94±1.55	9.47±1.06	3.126	0.004
LVEDV(mL)	89.06±36.91	116.80±26.45	-2.434	0.021
LVESV(mL)	29.22±10.24	42.47±11.49	-3.501	0.001
LVEF(%)	69.39±5.29	63.40±4.15	3.595	0.001
LVFS(%)	38.06±5.84	34.40±3.14	2.172	0.038
SV(mL)	65.44±21.20	74.07±17.49	-1.257	0.218

项目	术前	术后1年随访	t	P
AO（mm）	32.62±2.75	32.83±3.01	-0.189	0.852
LAD(mm)	47.08±6.50	41.67±5.65	2.213	0.037
LVEDd(mm)	45.77±4.22	45.58±3.68	0.117	0.908
LVESd(mm)	28.38±3.30	29.00±3.16	-0.475	0.639
IVSd(mm)	17.38±2.99	11.67±2.31	5.321	0.000
LVPWT(mm)	11.54±1.76	10.25±0.96	2.291	0.034
LVEDV(mL)	98.54±21.61	96.75±18.42	0.222	0.826
LVESV(mL)	32.15±9.36	34.00±9.12	-0.499	0.623
LVEF(%)	67.46±2.96	64.83±4.20	1.821	0.082
LVFS(%)	37.69±2.25	35.25±3.31	2.175	0.040
SV(mL)	66.38±12.96	62.42±11.82	0.797	0.433